Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01307384 · ClinicalTrials.gov registry record
Zimmer Continuum Metal on Polyethylene (MoP) PostMarket Clinical Followup (PMCF) Study
A clinical trial of Rheumatoid Arthritis and Osteoarthritis, sponsored by Zimmer Biomet.
- Active
- Registry status
- 165
- Enrollment target
- 2
- Study locations
NCT01307384: Active study of Rheumatoid Arthritis and Osteoarthritis, sponsored by Zimmer Biomet.
NCT01307384 is a study of Rheumatoid Arthritis and Osteoarthritis that is active but no longer recruiting, run by Zimmer Biomet. The registered enrollment target is 165 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01307384, a study of Rheumatoid Arthritis and Osteoarthritis, is active but no longer recruiting, sponsored by Zimmer Biomet.
- ACTIVE NOT RECRUITING
- Registry status
- 165 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a prospective, multi-center, non-randomized, non-controlled study designed to obtain survival and outcome data on the Continuum Metal on Polyethylene Acetabular System when used in primary total hip arthroplasty.
Primary Outcome
Based on removal or intended removal of the device and determined using the Kaplan-Meier method.
Conditions Studied
Interventions
- DEVICE Continuum Metal on Polyethylene Acetabular System
Study Locations (2)
California
- Sah Orthopaedic Associates - Fremont
Colorado
- Denver Health Medical Center - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2011-03-29 |
| Est. Completion | 2027-12 |
What the registry record for NCT01307384 still lists
NCT01307384 is an observational study that tracks outcomes without assigning an intervention. The registered 165 participants enrollment target is mid-sized for trials with a published cap, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (96% lower).
The record links to 5 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Continuum Metal on Polyethylene Acetabular System is the first listed.
NCT01307384 reports a single indexed study location in California, Colorado.
Frequently Asked Questions
What is clinical trial NCT01307384 about?
NCT01307384 is a clinical study titled "Zimmer Continuum Metal on Polyethylene (MoP) PostMarket Clinical Followup (PMCF) Study". This is a prospective, multi-center, non-randomized, non-controlled study designed to obtain survival and outcome data on the Continuum Metal on Polyethylene Acetabular System when used in primary total hip arthroplasty.
What is the current status of trial NCT01307384?
This trial is currently active not recruiting. The enrollment target is 165 participants. The study started on 2011-03-29. Estimated completion is 2027-12.
What conditions does trial NCT01307384 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis, Osteoarthritis, Avascular Necrosis, Post Traumatic Arthritis, Inflammatory Arthritis.
What interventions are being tested in trial NCT01307384?
The interventions under investigation include: Continuum Metal on Polyethylene Acetabular System (DEVICE).
Who is sponsoring clinical trial NCT01307384?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01307384 being conducted?
This trial has 2 study locations across California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01307384's enrollment target sits among peer trials
165 92nd of 197 higher than 106 of 197 other Rheumatoid Arthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Rheumatology Diet Study
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Study of GS-0151 in Participants With Rheumatoid Arthritis
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02387255 · 165 participants
Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms
- NCT03351348 · 165 participants · Phase 3
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
- NCT03830320 · 165 participants · Phase 1
Positron Emission Tomography (PET) Imaging of Thrombosis
- NCT04289571 · 165 participants · Phase 1
Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI